Impax Asset Management Group plc Makes New $660,000 Investment in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Impax Asset Management Group plc acquired a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 8,445 shares of the company's stock, valued at approximately $660,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Cherry Creek Investment Advisors Inc. grew its stake in GE HealthCare Technologies by 0.3% in the fourth quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company's stock worth $2,920,000 after purchasing an additional 114 shares in the last quarter. Independence Bank of Kentucky grew its stake in GE HealthCare Technologies by 6.0% in the fourth quarter. Independence Bank of Kentucky now owns 2,018 shares of the company's stock worth $158,000 after purchasing an additional 114 shares in the last quarter. Tandem Capital Management Corp ADV grew its stake in GE HealthCare Technologies by 0.4% in the fourth quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company's stock worth $2,205,000 after purchasing an additional 118 shares in the last quarter. Arcus Capital Partners LLC grew its stake in GE HealthCare Technologies by 3.0% in the fourth quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company's stock worth $322,000 after purchasing an additional 119 shares in the last quarter. Finally, Custom Index Systems LLC grew its stake in GE HealthCare Technologies by 4.4% in the fourth quarter. Custom Index Systems LLC now owns 2,843 shares of the company's stock worth $222,000 after purchasing an additional 120 shares in the last quarter. Institutional investors own 82.06% of the company's stock.

Remove Ads

GE HealthCare Technologies Stock Down 2.3 %

Shares of GE HealthCare Technologies stock traded down $2.05 during trading on Friday, reaching $87.35. The company's stock had a trading volume of 4,214,406 shares, compared to its average volume of 2,887,457. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The company has a market cap of $39.94 billion, a price-to-earnings ratio of 20.17, a P/E/G ratio of 3.19 and a beta of 1.15. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80. The company has a 50-day simple moving average of $86.17 and a two-hundred day simple moving average of $86.10.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to analysts' expectations of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on GEHC. Wells Fargo & Company lifted their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a report on Friday, February 14th. Citigroup lifted their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a report on Thursday, February 13th. Finally, Jefferies Financial Group upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $97.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.